ID   NZM053
AC   CVCL_D839
SY   NZM53
DR   Wikidata; Q54931588
RX   PubMed=20041153;
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
CC   Omics: Transcriptome analysis by microarray.
ST   Source(s): PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 10,12
ST   D16S539: 10,12
ST   D18S51: 14
ST   D19S433: 12,14
ST   D21S11: 27,32.2
ST   D2S1338: 18,20
ST   D3S1358: 14,15
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 12,14
ST   FGA: 20,22
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 15,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 11
//
RX   PubMed=20041153; DOI=10.1371/journal.pone.0008461; PMCID=PMC2794539;
RA   Jeffs A.R., Glover A.C., Slobbe L.J., Wang L., He S.-J., Hazlett J.A.,
RA   Awasthi A., Woolley A.G., Marshall E.S., Joseph W.R., Print C.G.,
RA   Baguley B.C., Eccles M.R.;
RT   "A gene expression signature of invasive potential in metastatic
RT   melanoma cells.";
RL   PLoS ONE 4:E8461-E8461(2009).
//
RX   PubMed=32567790; DOI=10.1111/pcmr.12908; PMCID=PMC7818249;
RA   Tran K.B., Gimenez G., Tsai P., Kolekar S., Rodger E.J.,
RA   Chatterjee A., Jabed A., Shih J.-H., Joseph W.R., Marshall E.S.,
RA   Wang Q., Print C.G., Eccles M.R., Baguley B.C., Shepherd P.R.;
RT   "Genomic and signalling pathway characterization of the NZM panel of
RT   melanoma cell lines: a valuable model for studying the impact of
RT   genetic diversity in melanoma.";
RL   Pigment Cell Melanoma Res. 34:136-143(2021).
//